Just published my latest research report. Analyzed Achieve Life Sciences $ACHV. Link in bio.
✅Great opportunity with x4 potential, perhaps more.
✅Upcoming NDA approval and financing are key catalysts.
✅Buyout highly likely in the next 12 months.
@david_katunaric $VLE.TO is a good example, pretty cheap, not too dependent on oil price with >50% of mc in cash and looking to acquire new fields.
Also $E.TO renting gas turbines to replace diesel for oil rigs, growing rapidly and very interesting unit economics.
DM me for more info if u like.
$GROY now up almost x3 since i published the thesis, a CAGR of >70%.
Great to see that things turn out as expected!!
More potential multibaggers and fresh ideas in my blog (link in bio)
$HFG CEO just bought 650,000 shares, which is ~0.4% of the company.
This follows a similar move a few months back where he purchased 1% of $HFG at similar prices.
ReFresh program is going very well and CEO took advantage of the market's short-term focus.
@_SirPeter ¿Trimestre débil? ¿Has leído el informe? Rebajan previsiones por el impacto de FX, el resto ha sido un Q muy bueno, FCF es 4 veces el de H1 2024, buenos márgenes y volverán al crecimiento $HFG
@Dividendopp I do too, they have proven to be very good capital allocators. Just take a look at the past acquisitions.
Also consider that we don't know the full picture and they might see other opportunities out there.
$VLE
1/2
Great deal today by $VLE $VLE.TO $VLERF. Short, near and long term organic growth for just $15M.
Still a lot of cash on the BS, which could now go to buybacks. The new fields will require investments but they may be financed with FCF.
Looking forward to more details on aug 7
My YTD returns have seen massive volatility. Went to +40% then down to +10% then back up again to +45% and now down to +2%.
Anyone else expericiencing this kind of volatily this year?
I'm confortable with it and knew it was a possibility but still it's surprising.
$HFG just ramped up their buyback to 300k shares/week and a board member bought another 13k shares.
This comes at a moment where the company is changin their strategy from growth towards FCF generation.
Q2 results to be released mid-August
@BioWino I think they may be waiting for NDA submission, since the warrants expire 30 days after it is submitted. If the warrants get executed they can get up to $60M. Warrants are at $4.90/share though so not sure if they will get executed.
Currently researching $ACHV, a very interesting opportunity.
Need for financing before August, either from existing warrants or new shareholders.
Even after 100% dilution (only if new shareholders enter) it could be a x4.
I will publish a thesis this weekend. Subscribe in bio.